Drug Information

Drug General Information
Drug ID
D0Y0FS
Former ID
DNC002424
Drug Name
6-Nitroindazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551393]
Formula
C7H5N3O2
Canonical SMILES
C1=CC2=C(C=C1[N+](=O)[O-])NN=C2
InChI
1S/C7H5N3O2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4H,(H,8,9)
InChIKey
ORZRMRUXSPNQQL-UHFFFAOYSA-N
PubChem Compound ID
24239
PubChem Substance ID
92375, 106062, 592911, 609765, 826400, 826426, 3134057, 5803796, 7736862, 7885466, 8139969, 8167695, 10535013, 11113657, 14772469, 17153724, 24897520, 29291326, 46504479, 49748239, 49982567, 51075372, 56423145, 57331634, 71833219, 78766667, 81043639, 87573744, 88814035, 92321658, 92712040, 103239666, 104126535, 104359722, 104669793, 117378587, 117378936, 118023947, 118083083, 124800346, 125357305, 126582033, 126630278, 126656972, 126670750, 126738811, 127324233, 127324234, 127324235, 127324236
Target and Pathway
Target(s) Nitric-oxide synthase, endothelial Target Info Inhibitor [551393]
Nitric oxide synthase, inducible Target Info Inhibitor [551393]
BioCyc Pathway Citrulline-nitric oxide cyclePWY-4983:Citrulline-nitric oxide cycle
KEGG Pathway Arginine and proline metabolism
Metabolic pathways
Calcium signaling pathway
cGMP-PKG signaling pathway
HIF-1 signaling pathway
Sphingolipid signaling pathway
PI3K-Akt signaling pathway
VEGF signaling pathway
Platelet activation
Estrogen signaling pathway
Oxytocin signaling pathwayhsa00220:Arginine biosynthesis
Peroxisome
Salmonella infection
Pertussis
Leishmaniasis
Chagas disease (American trypanosomiasis)
Toxoplasmosis
Amoebiasis
Tuberculosis
Pathways in cancer
Small cell lung cancer
NetPath Pathway Wnt Signaling PathwayNetPath_13:IL1 Signaling Pathway
IL2 Signaling Pathway
PANTHER Pathway Angiogenesis
Endothelin signaling pathway
Interleukin signaling pathway
PI3 kinase pathway
VEGF signaling pathway
Pathway Interaction Database Plasma membrane estrogen receptor signaling
Validated transcriptional targets of AP1 family members Fra1 and Fra2
Angiopoietin receptor Tie2-mediated signaling
Thromboxane A2 receptor signaling
SHP2 signaling
VEGFR1 specific signals
Signaling events mediated by VEGFR1 and VEGFR2
PAR1-mediated thrombin signaling eventsil12_2pathway:IL12-mediated signaling events
Alpha9 beta1 integrin signaling events
ATF-2 transcription factor network
IL23-mediated signaling events
Signaling mediated by p38-alpha and p38-beta
HIF-1-alpha transcription factor network
Reactome ROS production in response to bacteria
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
eNOS activation
Nitric oxide stimulates guanylate cyclase
VEGFR2 mediated vascular permeabilityR-HSA-1222556:ROS production in response to bacteria
WikiPathways ACE Inhibitor Pathway
EGF/EGFR Signaling Pathway
Myometrial Relaxation and Contraction Pathways
JAK/STAT
Corticotropin-releasing hormone
AGE/RAGE pathway
Endothelin Pathways
Leptin signaling pathway
Effects of Nitric Oxide
Metabolism of nitric oxide
AngiogenesisWP619:Type II interferon signaling (IFNG)
Spinal Cord Injury
References
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
Ref 551393How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.